Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/4/2025

Treatment of Nocturnal Urinary Incontinence in Adults

Initial Diagnostic Evaluation

  • The American Urological Association recommends performing a careful history, physical examination, and urinalysis to exclude urinary tract infection and other pathology in patients with nocturnal urinary incontinence 1, 2
  • Obtaining a voiding diary is essential to reliably measure urinary frequency, incontinence episodes, and voided volumes in patients with nocturnal urinary incontinence 2, 3
  • Differentiating between urgency urinary incontinence and nocturnal polyuria is crucial, with nocturnal polyuria characterized by normal or large volume voids representing >20-33% of 24-hour urine output, age-dependent 2, 3, 4
  • Assessing for comorbid conditions, including sleep apnea, vascular/cardiac disease, neurologic disorders, and diabetes, is necessary as they commonly cause nocturnal polyuria 2, 5

First-Line Treatment: Behavioral Interventions

  • The American Urological Association recommends initiating behavioral treatments first, with consideration of adding antimuscarinic therapy if partially effective, for patients with nocturnal urinary incontinence 1
  • Establishing treatment goals collaboratively with the patient and discussing normal urinary tract function along with benefits/risks of treatment alternatives is essential 1, 2

Second-Line Treatment: Antimuscarinic Medications

  • The American Urological Association recommends adding antimuscarinic medications with active management of adverse events if behavioral treatments are insufficient or only partially effective for patients with nocturnal urinary incontinence 1
  • Actively managing common adverse events, including dry mouth and constipation, through dose modification or switching to an alternate antimuscarinic is necessary if effective but intolerable 1

Targeted Treatment for Nocturnal Polyuria

  • Addressing underlying cardiovascular, renal, or sleep disorders contributing to nocturnal polyuria is crucial for patients with nocturnal polyuria 2, 5

Critical Pitfalls to Avoid

  • The American Urological Association emphasizes the importance of not failing to distinguish between mixed incontinence subtypes, as this leads to inappropriate treatment selection 2, 5
  • Not neglecting follow-up for treatment efficacy and adverse event management is essential for optimizing outcomes in patients with nocturnal urinary incontinence 1

Combination Therapy Considerations

  • The 2019 AUA/SUFU guideline amendment specifically addresses combination therapy for overactive bladder, though behavioral treatments combined with antimuscarinics remain the standard stepwise approach 2, 3, 4